A novel ex vivo organotypic culture model of alkaptonuria-ochronosis

Clinical and Experimental Rheumatology

Volumn 29, Issue 4, 2011, Pages 693-696

  Tinti, Laura ^a   Spreafico, Adriano ^a   Chellini, Federico ^a   Galeazzi, Mauro ^a   Santucci, Annalisa ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Alkaptonuria; Cartilage; Homogentisic acid; Ochronosis

Indexed keywords

HOMOGENTISIC ACID;

ALKAPTONURIA; ARTICLE; CARTILAGE; EX VIVO ORGANOTYPIC CULTURE MODEL; EX VIVO STUDY; HUMAN; HUMAN TISSUE; OCHRONOSIS; PIGMENTATION; PRIORITY JOURNAL; TISSUE CULTURE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; TIME; TISSUE CULTURE TECHNIQUE;

CARTILAGE; HOMOGENTISIC ACID; HUMANS; OCHRONOSIS; OXIDATION-REDUCTION; PIGMENTATION; TIME FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 80055118329     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Orphanet Report Series-Prevalence of rare diseases: Bibliographic data-May 2010-Number1:http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf
2. Fernández-Cañón JM, Granadino B, Beltrán-Valero DE Bernabé D et al.: The molecular basis of alkaptonuria. Nat Genet 1996; 14: 19-24.
3. Phornphutkul C, Introne WJ, Perry MB et al.: Natural history of alkaptonuria. N Engl J Med 2002 Dec 26; 347: 2111-21. PubMed PMID: 12501223. http://clinicaltrials.gov/ct2/show/NCT00107783
4. Braconi D, Laschi M, Taylor A et al.: Proteomic And Redox-Proteomic Evaluation Of Homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem 2010; 111: 922-32.
5. Tinti L, Taylor Am, Santucci A et al.: Development Of An In Vitro Model To Investigate Joint ochronosis in alkaptonuria. Rheumatology (Oxford) 2011; 50: 271-7.
6. Tinti L, Spreafico A, Braconi D et al.: Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol 2010; 225: 84-91.
7. Braconi D, Laschi M, Amato L et al.: Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) 2010; 49: 1975-83.
8. Taylor AM, Wlodarski B, Prior IA et al.: Ultrastructural examination of tissue in a patient with alkaptonuric arthropathy reveals a distinct pattern of binding of ochronotic pigment. Rheumatology (Oxford). 2010; 49: 1412-4.
9. Taylor AM, Wilson PJ, Ingrams DR, Helliwell TR, Gallagher JA, Ranganath LR: Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria. J Clin Pathol 2010; 63: 186-8.
10. Montagutelli X, Lalouette A, Coude' M, Kamoun P, Forest M, Guénet Jl: Aku, A Mutation Of The mouse homologous to human alkaptonuria, maps to chromosome 16. Genomics 1994; 19: 9-11.
11. Taylor AM, Preston A, Paulk NK et al.: Identification of joint ochronosis in a mouse model of alkaptonuria. Osteoarthritis Cartilage 2010; 18 (Suppl. 2): S45-S256.
12. Angeles AP, Badger R, Gruber HE, Seegmiller JE: Chondrocyte growth inhibition induced by homogentisic acid and its partial prevention with ascorbic acid. J Rheumatol 1989; 16: 512-7.
13. Kirkpatrick CJ, Mohr W, Mutschler W: Experimental Studies On The Pathogenesis Of Ochronotic arthropathy. The effects of homogentisic acid on adult and fetal articular chondrocyte morphology, proliferative capacity and synthesis of proteoglycans in vitro. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 47: 347-60.
14. www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=148701
15. www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000555/human_med_000959.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d125